Morphological substrates of dementia in parkinsonism. A critical update

Journal of Neural Transmission, Supplement

Volumn , Issue 51, 1997, Pages 57-82

  Jellinger, K A ^a  

^a INSTITUTE OF CLINICAL NEUROBIOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; BRAIN DEGENERATION; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; CONFERENCE PAPER; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; HUMAN TISSUE; LEWY BODY; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; NERVE CELL LESION; NEUROPATHOLOGY; NORADRENERGIC SYSTEM; PARKINSONISM; PRIORITY JOURNAL; SENILE PLAQUE; SEROTONINERGIC SYSTEM; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BRAIN; BRAIN CORTEX; MIDDLE AGED; NERVE DEGENERATION; PARKINSON DISEASE; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

DOPAMINE; NORADRENALIN; SEROTONIN;

AGED; AMYGDALA; AUTONOMIC NERVOUS SYSTEM; BRAIN; CEREBRAL CORTEX; DEMENTIA; DOPAMINE; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE DEGENERATION; NOREPINEPHRINE; PARKINSON DISEASE; SEROTONIN;

EID: 0031283218     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6846-2_6     Document Type: Conference Paper

References (136)

1. Agid Y, Graybiel AM, Ruberg M, Hirsch E, Blin J, Dubois B, Javoy-Agid F (1990) The efficacy of levodopa treatment declines in the course of Parkinson's disease. Do non-dopaminergic lesions play a role? Adv Neurol 53: 83-100
2. Albin RL (1995) The pathophysiology of chorea/ballism and parkinsonism. Parkinsonism Rel Disord 1: 3-11
3. Allard PO, Rinner J, Marcusson JO (1995) Dopamine uptake sites in Parkinson's disease and in dementia of the Alzheimer type. Brain Res 637: 262-266
4. Amaral DG, Price JL, Pitkänen A, Carmichael ST (1992) Anatomical organization of the primate amygdaloid complex. In: Aggleton JP (ed) The amygdala: neurobiological aspects of emotion, memory, and mental dysfunction. Wiley-Liss, New York, pp 1-66
5. Arai H, Schmidt ML, Lee VM-Y, Hurtig HI, Greenberg BD, Adler CH, Trojanowski JQ (1992) Epitope analysis of senile plaque components in the hippocampus of patients with Parkinson's disease. Neurology 42: 1315-1322
6. Arriagada PV, Marzloff K, Hyman BT (1992) Distribution of Alzheimer-type pathologic changes in non-demented elderly individuals matches the pattern in Alzheimer's disease. Neurology 42: 1681-1688
7. Bancher C, Braak H, Fischer P, Jellinger K (1993) Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease. Neurosci Lett 162: 179-182
8. Bancher C, Jellinger K, Lassmann H, et al (1996) Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia. Eur Arch Psychiatry Clin Neurosci 246: 137-146
9. Berlit P (1987) Neurologischer Diagnoseschlüssel der internationalen Klassifikation der Krankheiten der WHO (ICD-NA). Springer, Berlin Heidelberg New York Tokyo
10. Bierer LM, Hof PR, Purohit DP, Carlin L, Schmeidler J, Davis KL, Perl DP (1995) Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol 52: 81-88
11. Biggins CA, Boyd JL, Harrop FM, Madeley P, Mindham RHS, Randall JI, Spokes EGS (1992) A controlled, longitudinal study of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 55: 566-571
12. Boller F, Mizutani T, Roessmann U, Gambetti P (1980) Parkinson's disease, dementia, and Alzheimer's disease. Clinico-pathological correlations. Ann Neurol 7: 329-335
13. Bouras C, Hof PR, Morrison JH (1993) Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes. Neurosci Lett 153: 131-135
14. Braak H, Braak E (1990) Cognitive impairment in Parkinson's disease: amyloid plaques, neurofibrillary tangles, and neuropil threads in the cerebral cortex. J Neural Transm [P-D Sect] 2: 45-57
15. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259
16. Braak H, Braak E (1992) The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases. Neurosci Res 15: 6-31
17. Braak H, Braak E (1994) Pathology of Alzheimer's disease. In: Calne DB (ed) Neurodegenerative disease. Saunders, Philadelphia, pp 585-613
18. Braak H, Jellinger K, Braak E, Bohl J (1992) Allocortical neurofibrillary changes in progressive supranuclear palsy. Acta Neuropathol 64: 478-483
19. Braak H, Duyckaerts C, Braak E, Piette F (1993) Neuropathological staging of Alzheimer-related changes correlates with psychometrically assessed intellectual status. In: Corain B, et al (eds) Alzheimer's disease. Advances in clinical and basic research. John Wiley, New York, pp 131-137
20. Braak H, Braak E, Yilmazer D, De Ros RAI, Jansen ENH, Bohl J, Jellinger K (1994) Amygdala pathology in Parkinson's disease. Acta Neuropathol 88: 493-500
21. Braak H, Braak E, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87: 554-567
22. Brooks DJ (1993) Functional imaging in relation to parkinsonian syndromes. J Neurol Sci 115: 1-17
23. Buée-Scherrer V, Buée L, Hof PR, Leveugle-Giolles C, Loerzel AJ, Perl DP, Delacourte A (1995) Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism dementia complex of Guam: immunochemical characterization of tau proteins. Am J Pathol 68: 924-932
24. Caporro-Lefevre D, Pecheus N, Petit Y, Duhamel A, Petit H (1995) Which factors predict cognitive decline in Parkinson's disease? J Neurol Neurosurg Psychiatry 58: 51-55
25. Chan-Palay V (1993) Depression and dementia in Parkinson's disease: catecholaminergic changes in the locus ceruleus. A basis for therapy. Adv Neurol 60: 438-446
26. Chan-Palay V, Hochli M, Jentsch B, Leonard B, Zetzsche T (1992) Raphe serotonin neurons in the human brain in normal controls and patients with senile dementia of the Alzheimer type and Parkinson's disease. Dementia 3: 253-269
27. Chui HC, Mortimer JA, Slager U (1986) Pathologic correlates of dementia in Parkinson's disease. Arch Neurol 43: 991-995
28. Curren T, Lang AE (1994) Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses. Mov Disord 9: 508-520
29. Daniel SE, Lees AJ (1991) Neuropathological features of Alzheimer's disease in non-demented parkinsonian patients. J Neurol Neurosurg Psychiatry 54: 972-975
30. Dickson DW, Schmidt ML, Lee VMY, Zhao ML, Yen SH, Trojanowski JQ (1994) Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease. Acta Neuropathol 87: 269-276
31. DSM-III-R (1987) Diagnostic and statistical manual of mental disorders, 3rd edn, revised. American Psychiatric Association, Washington
32. Dubois B, Boller F, Pillon B, Agid Y (1991) Cognitive deficits in Parkinson's disease. In: Boller F, Grafman J (eds) Handbook of neuropsychology, vol 5. Elsevier, Amsterdam, pp 195-240
33. Dubois B, Malapani C, Verin M, Rogelet P, Deweer B, Pillon B (1994) Cognitive functions and the basal ganglia. The model of Parkinson's disease. Rev Neurol 150: 763-770
34. Duyckaerts C, Gaspar P, Costa C, Bonnet M, Hauw JJ (1993) Dementia in Parkinson's disease. Morphometric data. Adv Neurol 60: 447-455
35. Fearnley J, Lees A (1994) Pathology of Parkinson's disease. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 545-554
36. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 12: 189-198
37. Friedman A, Barczikowska M (1994) Dementia in Parkinson's disease. Dementia 5: 12-16
38. Gai WP, Blessing WW, Blumbergs PC (1995) Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease. Brain 118: 1447-1459
39. Gaspar P, Gray F (1984) Dementia in idiopathic Parkinson's disease. A neuropathological study of 32 cases. Acta Neuropathol 64: 43-52
40. Gaspar P, Duyckaerts C, Alvarez C, Javoy-Agid F, Boger B (1991) Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease. Ann Neurol 30: 365-374
41. Gerlach M, Riederer P (1993) The pathophysiological basis of Parkinson's disease. In: Szeleny I (ed) Inhibitors of monoamine oxidase B. Pharmacology and clinical use in neurodegenerative disorders. Birkhäuser, Basle, pp 25-50
42. Gerlach M, Jellinger K, Riederer P (1994) The possible role of noradrenergic deficits in selected signs of Parkinson's disease. In: Briley M, Marien M (eds) Noradrenergic mechanisms in Parkinson's disease. CRC Press, Boca Raton, pp 59-71
43. German DC, Manaye KF, White CL (1992) Disease specific patterns of locus ceruleus cell loss. Ann Neurol 32: 667-676
44. Groenewegen JH, Roeling T, Voorn P, Berendse H (1993) The parallel arrangement of basal ganglia-thalamocortical circuits: a neuronal substrate for the role of dopamine in motor and cognitive functions? In: Wolters EC, Scheltens P (eds) Mental dysfunction in Parkinson's disease. Vrije Universiteit, Amsterdam, pp 3-18
45. Halliday GM, McCann HL, Pamphlett R, et al (1992) Brain stern serotonin-synthesizing neurons in Alzheimer's disease: a clinico-pathologic correlation. Acta Neuropathol 84: 638-650
46. Hansen LA, Masliah E, Quidjada-Fawcett S, Rexin D (1991) Entorhinal neurofibrillary tangles in Alzheimer's disease with Lewy bodies. Neurosci Lett 129: 269-272
47. Hansen LA, Masliah E, Galasko D, Terry RD (1993) Plaque-only Alzheimer disease is usually the Lewy body variant and vice versa. J Neuropathol Exp Neurol 52: 648-654
48. Hardy J, Crook R, Prihar G, Roberts G, Raghavan R, Perry R (1994) Senile dementia of the Lewy body type has an apolipoprotein E epsilon 4 allele frequency intermediate between controls and Alzheimer's disease. Neurosci Lett 182: 1-2
49. Harrington CR, Perry RH, Perry EK, Hurt J, McKeith IG, Roth M, Wischik CM (1994a) Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. Dementia 5: 215-228
50. Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK, Xuereb JH, Roth M, Wischik CM (1994b) Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Am J Pathol 145: 1472-1484
51. Hedera P, Lerner AJ, Castellani R, Friedland RP (1995) Concurrence of Alzheimer's disease, Parkinson's disease, diffuse Lewy body disease, and amyotrophic lateral sclerosis. J Neurol Sci 128: 219-224
52. Heinonen O, Soininen H, Sorvari H, Kosunen O, Paljärvi I, Koivisto E, Riekkienen PJ (1995) Loss of synaptophysin-like immunoreactivity in the hippocampal formation as an early phenomenon in Alzheimer's disease. Neuroscience 64: 375-384
53. Hoehn MM, Yahr M (1967) Parkinsonism. Onset, progression, and mortality. Neurology 17: 427-442
54. Hof PR, Morrison JH (1994) The cellular basis of cortical disconnection in Alzheimer disease and related dementing conditions. In: Terry RD, Katzmann R, Bick KL (eds) Alzheimer disease. Raven Press, New York, pp 197-229
55. Hof PR, Nimchinsky EA, Buée-Scherrer V, Buée L, Nasrallah J, Hottinger AF, Purohit DP, Loerzel AJ, Steele JC, Delacourte A, Bouras C, Morrison JH, Perl DP (1994) Amyotrophic lateral sclerosis/parkinsonism-demetia complex of Guam: quantitative neuropathology, immunohistochemical analysis of neuronal vulnerability, and comparison with related neurodegenerative disorders. Acta Neuropathol 88: 397-404
56. Hoogendijk WJG, Pall CW, Troost D, Venzweiten E, Swaab DF (1995) Image analysis-assisted morphometry of the locus ceruleus in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Brain 118: 131-143
57. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease. A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184
58. Hyman BT, Van Hoesen GW, Kromer LJ, Damasio AR (1986) Perforant pathway changes and the memory impairment in Alzheimer disease. Ann Neurol 20: 37-40
59. Ince PG, McArthur FK, Bjertness E, Torvik A, Condy JM, Edwardson JA (1995) Neuropathological diagnosis in elderly patients in Oslo - Alzheimer's disease, Lewy body disease, vascular lesions. Dementia 6: 162-166
60. Insausti R, Tunon T, Sobreviela T, Insausti AM, Gonzalo LM (1995) The human entorhinal cortex. A cytoarchitectonic analysis. J Comp Neurol 355: 171-198
61. Javoy-Agid F, Scatton B, Ruberg M, L'Heureux L, Cervera P, Raisman R, Maloteaus JM, Beck H, Agid Y (1989) Distribution of monoaminergic, cholinergic and gabaergic markers in the human cerebral cortex. Neuroscience 29: 251-269
62. Jellinger K (1987) Neuropathological substrates of Alzheimer's and Parkinson's disease. J Neural Transm [Suppl] 24: 109-129
63. Jellinger K (1990) New developments in the pathology of Parkinson's disease. Adv Neurol 53: 1-16
64. Jellinger K (1991) Pathology of Parkinson's disease: changes other than the nigro-striatal pathway. Mol Chem Neuropathol 14: 153-198
65. Jellinger K (1994) Structural basis of dementia in Parkinson's disease. In: Korczyn AD (ed) Dementia in Parkinson's disease. Monduzzi Ed, Bologna, pp 31-38
66. Jellinger KA, Bancher C (1995) Structural basis of mental impairment in Parkinson's disease. Neuropsychiatric 9: 9-14
67. Jellinger KA, Bancher C (1996) Dementia with Lewy bodies. Relationship to Parkinson's and Alzheimer's disease. In: Perry E, McKeith JG (eds) Dementia with Lewy bodies. Cambridge University Press, New York, pp 268-286
68. Jellinger K, Braak H, Braak E, Fischer P (1991) Alzheimer lesions in the entorhinal region and isocortex in Parkinson's and Alzheimer's diseases. Ann NY Acad Sci 640: 203-209
69. Jellinger KA, Bancher C, Fischer P (1993) Neuropathological correlates of mental dysfunction in Parkinson's disease. In: Wolters ECh, Schelten S (eds) Mental dysfunction in Parkinson's disease. Vrije Universiteit, Amsterdam, pp 141-161
70. Jones RSG (1993) Entorhinal-hippocampal connections: a speculative view of their function. Trends Neurosci 16: 58-64
71. Kazee AM, Han LY (1995) Cortical Lewy bodies in Alzheimer's disease. Arch Pathol Lab Med 119: 448-453
72. Khachaturian ZS (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42: 1097-1105
73. Klingberg T, Roland PE, Kawashima (1994) The human entorhinal cortex participates in associative memory. Neuro Report 6: 57-60
74. Koller WC, Glatt SL, Rubble JP (1995) Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Ann Neurol 37: 242-245
75. Kosaka K (1993) Dementia and neuropathology in Lewy body disease. Adv Neurol 60: 456-463
76. Langlais PJ, Thal L, Hansen L, Galasko D, Alford M, Masliah E (1993) Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies. Neurology 43: 1927-1934
77. Lassmann H, Weiler R, Fischer P, Bancher C, Jellinger K, et al (1992) Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense core vesicles. Neuroscience 46: 1-8
78. Lassmann H, Fischer P, Jellinger K (1993) Synaptic pathology of Alzheimer's disease. Ann NY Acad Sci 695: 59-64
79. Lehericy S, Hirsch EC, Pervera-Plerot P, Javoy-Agid F, Agid Y (1993) Heterogeneity of the degeneration of cholinergic neurons in basal forebrain in patients with Alzheimer's disease. J Comp Neurol 330: 15-31
80. Lippa CF, Smith TW, Swearer JM (1994) Alzheimer's disease and Lewy body disease: a comparative clinicopathological study. Ann Neurol 35: 81-88
81. Lippa CF, Smith TW, Saunders AM, et al (1995) Apolipoprotein E genotype and Lewy body disease. Neurology 45: 97-103
82. Louis ED, Goldman JE, Powers JM, Fahn S (1995) Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body disease. Mov Disord 10: 188-194
83. Love S, Wilcock GK, Matthews SM (1995) No correlation between nigral degeneration and striatal plaques in Alzheimer's disease. Acta Neuropathol 91: 432-435
84. Manaye KF, Woodward K, Mclntire DD, Mann DMA, German DC (1994) Locus coeruleus cell loss on lobar atrophy. Neurodegeneration 3: 205-210
85. Marder K, Leung D, Tang M, Bell K, Doonelef G, Cote L, Stern Y, Mayeux R (1991) Are demented patients with Parkinson's disease accurately reflected in prevalence surveys? A survival analysis. Neurology 41: 1240-1243
86. Marder K, Cote L, Tang M, Stern Y, Maestre G, Tycko B, Mayeux R (1994) The risk and predictive factors associated with dementia in Parkinson's disease. In: Korczyn AD (ed) Dementia in Parkinson's disease. Monduzzi Ed, Bologna, pp 51-54
87. Marie RM, Barre L, Rioux P, Allain P, Lechevalier B, Baron JC (1995) PET imaging of neocortical monoaminergic terminals in Parkinson's disease. J Neural Transm [PD-Sect] 9: 55-71
88. Masliah E (1995) Mechanisms of synaptic dysfunction in Alzheimer's disease. Histol Histopathol 10: 505-519
89. Mayeux R, Denaro J, Hemenglido N, Marder K Tang MX, Cote LJ, Stern Y (1992) A population-based investigation of Parkinson's disease with and without dementia. Arch Neurol 49: 492-497
90. McKeith IG, Fairbairn AF, Bothwell RA, et al (1994) An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 44: 872-877
91. Mindham RHS, Biggins CA, Boyd JL, et al (1993) A controlled study of dementia in Parkinson's disease over 54 months. Adv Neurol 60: 469-474
92. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Van Belle G, Berg L (1991) The Consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486
93. Morris CM, Massey HM, Benjamin R, et al (1996) Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias. J Neural Transm [Suppl] 47: 205-218
94. Mufson EJ, Conner JM, Kordower JH (1995) Nerve growth factor in Alzheimer's disease. Defective retrograde transport to nucleus basalis. Neuroreport 6: 1063-1066
95. Murray AM, Weihmueller FB, Marshall JF, Hurtig HI, Gottleib GL, Joyce JN (1995) Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism. Ann Neurol 37: 300-312
96. Nieuwenhuys R, Voogel J, Van Huizen C (1988) The human central nervous system. A synopsis and atlas, 3rd ed. Springer, Berlin Heidelberg New York Tokyo
97. Parent A, Hazrati L-N (1995) Functional anatomy of the basal ganglia. I. The corticobasal-ganglia-thalamo-corticol loop. Brain Res Rev 20: 91-127
98. Paulus W, Jellinger K (1991) The neuropthologic basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 50: 743-755
99. Pendlebury WW, Perl D (1984) Nucleus basalis of Meynert. Severe loss in Parkinson's disease without dementia (Abstr). Ann Neurol 16: 129
100. Peppard RF, Martin WRW, Carr GD, Grochoswski E, Schulzer M, et al (1992) Cerebral glucose metabolism in Parkinson's disease with and without dementia. Arch Neurol 49: 1262-1268
101. Perry EK, Irving D, Kerwin JM, McKeith IG, Thompson P, Collerton D, Fairbairn AP, Ince PG, Morris CM, Cheng AV, Perry RM (1993) Cholinergic transmitter and neurotrophic activities in Lewy body dementia. Similarity to Parkinson's and distinction from Alzheimer disease. Alzheimer Dis Assoc Disord 7: 69-79
102. Perry EK, Morris CM, Court JA, Choung A, Fairbairn AF, McKeith JG, Irving D, Brown A, Perry RH (1995) Alteration in nicotin binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience 64: 385-395
103. Pillon B, Deweer B, Malapani C, Regelet P, Agid Y, Dubois B (1994a) Explicit memory disorders of demented parkinsonian patients and underlying neuronal basis. In: Korczyn AD (ed) Dementia in Parkinson's disease. Monduzzi Ed, Bologna, pp 265-271
104. Pillon B, Michon A, Malapani C, Agid Y, Dubois B (1994b) Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's and Huntington's diseases. Neurology 44: 1264-1270
105. Playford ED, Jenkins IH, Passingham RF, Nutt J, Frackowiak RSJ, Brooks DJ (1992) Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Ann Neurol 32: 151-161
106. Reid WJG, Broe, GA, Morris JGL (1992) The role of cholinergic deficiency in neuropsychological deficits in idiopathic Parkinson's disease. Dementia 3: 114-120
107. Ring HA, Bench CJ, Trimble MR, Brooks DJ, Frakowiak RSJ, Dolan RJ (1994) Depression in Parkinson's disease. A positron emission study. Br J Psychiatry 165: 333-339
108. Rinne JO, Rummukainen J, Paljärvi J, Rinne UK (1989) Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra. Ann Neurol 26: 47-50
109. Rolls ET (1994) Neurophysiology and cognitive functions of the striatum. Rev Neurol 150: 648-660
110. Ruberg M, Agid Y (1988) Dementia in Parkinson's disease. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, vol 20. Psychopharmacology of aging nervous system. Plenum Press, New York, pp 157-206
111. Samuel W, Masliah E, Hikll R, Butters N, Terry R (1994a) Hippocampal connectivity and Alzheimer's dementia: effects of synapse loss and tangle frequency in a two-component model. Neurology 44: 2081-2088
112. Samuel W, Terry RD, DeTeresa R, et al (1994b) Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia. Arch Neurol 51: 772-778
113. Samuel W, Galasko D, Masliah E, Hansen LA (1996) Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. J Neuropathol Exp Neurol 55: 44-52
114. Saper CD, German DC, White CL (1985) Neuronal pathology in the nucleus basalis of Meynert and associated cell groups in senile dementia of the Alzheimer's type. Possible role of cell loss. Neurology 35: 1089-1095
115. Sawaguchi T, Goldman-Rakic PS (1991) D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 251: 247-250
116. Scott SA, DeKosky ST, Sparks DL, Knox CA, Scheff SW (1992) Amygdala cell loss and atrophy in Alzheimer's disease. Ann Neurol 32: 555-563
117. Sims KS, Williams RS (1990) The human amygdaloid complex. Neuroscience 36: 449-472
118. Smith MA, Perry G (1994) Is a Lewy body always a Lewy body? In: Korczyn AD (ed) Dementia in Parkinson's disease. Monduzzi Ed, Bologna, pp 187-193
119. Steriade M, Biesold D (1990) Brain cholinergic systems. Oxford University Press
120. Stern Y, Marder K, Tang MX, Mayeux R (1993) Antecedent clinical features associated with dementia in Parkinson's disease. Neurology 43: 1690-1692
121. Stern Y, Richards M, Sano M, Mayeux R (1993) Comparison of cognitive changes in patients with Alzheimer's and Parkinson's disease. Arch Neurol 50: 1040-1045
122. Strong C, Anderton BH, Perry RH, et al (1995) Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer disease; evidenced that the disorders are distinct. Alzheimer Dis Assoc Disord 9: 215-222
123. Tagliavini F, Pilleri G, Bouras C, Constantinidis J (1984) The basal nucleus of Meynert in idiopathic Parkinson's disease. Acta Neurol Scand 69: 20-28
124. Tatemichi TK, Sacktor N, Mayeux R (1994) Dementia associated with cerebrovascular disease, other degenerative diseases, and metabolic disorders. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer disease. Raven Press, New York, pp 123-166
125. Terry RD, Masliah E, Salmon DP (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30: 572-580
126. Terry RD, Masliah E, Hansen LA (1994) Structural basis of the cognitive alterations in Alzheimer's disease. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer disease. Raven Press, New York, pp 179-196
127. Tison F, Dartigues JF, Auriacombe S, Letenneur L, Boller F, Alperovich A (1995) Dementia in Parkinson's disease. A population-based study in ambulatory and institutionalized individuals. Neurology 45: 705-708
128. Troster AL, Paolo AM, Lyons KE, Glatt SL, Hubble JP, Koller WC (1995) The influence of depression on cognition in Parkinson's disease. A pattern impairment distinguishable from Alzheimer's disease. Neurology 45: 672-676
129. Uitti RJ, Berry K, Yasuhara O, et al (1995) Neurodegenerative "overlap" syndrome: clinical and pathological features of Parkinson's disease, motor neuron disease, and Alzheimer's disease. Park Rel Dis 1: 21-34
130. Vereecken ThHLG, Vogels OJM, Nieuwenhuys R (1994) Neuron loss and shrinkage in the amygdala in Alzheimer's disease. Neurobiol Aging 15: 45-54
131. Vermersch P, Frigard B, Delacourte A (1992) Mapping of neurofibrillary degeneration in Alzheimer's disease; evaluation of heterogeneity using the quantification of abnormal tau proteins. Acta Neuropathol 85: 48-54
132. Vermersch P, Delacourte A, Javoy-Agid F, Hauw JJ, Agid Y (1993) Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal tau proteins. Ann Neurol 33: 445-450
133. Vermersch P, Robitaille Y, Bernier L, et al (1994) Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement. Acta Neuropathol 87: 572-577
134. Xuereb JH, Tomlinson BE, Irfing D, et al (1990) Cortical and subcortical pathology in Parkinson's disease: relationship to parkinsonian dementia. Adv Neurol 53: 35-40
135. Zubenko GS (1992) Biological correlates of clinical heterogeneity in primary dementia. Neuropsychopharmacology 6: 72-93
136. Zweig RM, Cardilio JE, Cohen M, Giere S, Hedreen JC (1993) The locus ceruleus and dementia in Parkinson's disease. Neurology 43: 986-991